Summary
Samenvatting Oncologie en palliatieve zorgen - VZC3 - Deel Ilse Demarès
- Course
- Institution
samenvatting van de lessen en ingesproken ppts
[Show more]
Seller
Followmarthebraem
Reviews received
Content preview
Verpleegkundige zorgOncologie en palliatieve zorg – Ilse Demarès
hoofdstuk 1: Hematologische oncologie..............................................................................5
1 de hematopoëse..............................................................................................................................5
2 Leukemie.........................................................................................................................................6
2.1 Oorzaak.......................................................................................................................................................6
3 Symptomen leukemie......................................................................................................................6
4 Soorten leukemie.............................................................................................................................7
4.1 Acuut...........................................................................................................................................................7
Kenmerken...................................................................................................................................................7
Gevolgen......................................................................................................................................................7
Symptomen..................................................................................................................................................7
4.2 Chronisch....................................................................................................................................................7
Kenmerken...................................................................................................................................................7
5 Acute myeloïde leukemie (AML)......................................................................................................7
4.1 Symptomatologie.......................................................................................................................................7
4.2 Diagnostiek.................................................................................................................................................8
4.3 Behandeling................................................................................................................................................8
Standaardbehandeling.................................................................................................................................8
Behandeling van de oudere patiënt.............................................................................................................8
4.4 Prognose.....................................................................................................................................................8
6 chemotherapie................................................................................................................................8
Bijwerkingen chemotherapie...........................................................................................................................8
Inductiefase......................................................................................................................................................8
Consolidatiefase...............................................................................................................................................9
Tumorlysis syndroom...................................................................................................................................9
Preventie TLS.......................................................................................................................................................... 9
Hematopoëtische stamceltransplantatie (HSCT).............................................................................................9
Transplantperiode......................................................................................................................................10
Mogelijke problemen ten gevolge van stamceltransplantatie..............................................................................11
Mogelijke problemen in de post-transplantperiode..............................................................................................11
autologe HSCT............................................................................................................................................11
Allogene HSCT............................................................................................................................................11
Hoofdstuk 2: het maligne lymfoom...................................................................................12
1 hodgkinlymfoom............................................................................................................................12
1.1 Incidentie..................................................................................................................................................12
Bifasische incidentiecurve..........................................................................................................................12
1
, 1.2 Histopathologie........................................................................................................................................12
1.3 Symptomen..............................................................................................................................................12
1.4 Behandeling..............................................................................................................................................13
Voor stadium I en II met gunstige prognostische factoren....................................................................... 13
Voor stadium III en IV.................................................................................................................................13
1.5 Prognose en late effecten.........................................................................................................................13
Stadium I en II............................................................................................................................................ 13
Stadium III en IV.........................................................................................................................................13
2 Non-hodgkinlymfoom (NHL)..........................................................................................................13
2.1 Symptomen..............................................................................................................................................13
2.2 Stadia........................................................................................................................................................14
2.3 Behandeling..............................................................................................................................................14
Traag-groeiend NHL...................................................................................................................................14
Stadium III en IV bij patiënten > 60j en asymptomatisch......................................................................................14
Stadium III en IV bij jongere patiënten..................................................................................................................14
agressieve lymfomen.................................................................................................................................14
hoofdstuk 3: multipel myeloom........................................................................................15
1 incidentie.......................................................................................................................................15
2 symptomen....................................................................................................................................15
3 Behandeling...................................................................................................................................16
3.1 Jonger dan 65 jaar....................................................................................................................................16
3.2 Ouder dan 65 jaar.....................................................................................................................................16
4 Prognose........................................................................................................................................16
Hoofdstuk 4: hematopoetische stamceltransplantatie (HSCT)...........................................16
1 pre-transplantonderzoeken...........................................................................................................16
2 Conditionering...............................................................................................................................16
2.1 Potentiële complicaties van chemotherapie............................................................................................17
3 ATG................................................................................................................................................17
1 Bijwerkingen................................................................................................................................................17
4 TBI..................................................................................................................................................17
4.1 Verpleegkundige aandachtspunten.........................................................................................................17
5 Toediening van immunosuppressiva.............................................................................................17
5.1 Verpleegkundige aandachtspunten.........................................................................................................18
6 Toediening van de stamcellen.......................................................................................................18
6.1 Mogelijke complicaties op korte termijn.................................................................................................18
1. Risicofactoren op ontwikkelen van VOD................................................................................................18
Verpleegkundige aandachtspunten VOD...................................................................................................18
2
, Behandeling VOD.......................................................................................................................................18
2. Risicofactoren op het ontwikkelen van GVHD.......................................................................................18
Huid............................................................................................................................................................19
Maagdarmstelsel........................................................................................................................................19
Lever...........................................................................................................................................................19
Chronische GVHD (> 3 maand)...................................................................................................................19
Complicaties op langere termijn................................................................................................................19
hoofdstuk 5: andere complicaties van de behandeling van hematologische maligniteiten.19
hoofdstuk 6: Bot- en wekedelenoncologie.........................................................................19
hoofdstuk 7: Neuro-oncologie (hersentumoren)................................................................19
1 oorzaak..........................................................................................................................................19
2 Erfelijkheid.....................................................................................................................................20
3 Hersentumoren bij kinderen..........................................................................................................20
4 Soorten hersentumoren................................................................................................................20
1 Primair.........................................................................................................................................................20
2 Secundair.....................................................................................................................................................20
5 Classificatie....................................................................................................................................20
5.1 Agressiviteit..............................................................................................................................................20
5.2 Lokalisatie.................................................................................................................................................20
5.3 Pathologie.................................................................................................................................................20
6 symptomen....................................................................................................................................20
6.1 Meest voorkomende klachten.................................................................................................................20
Hoofdpijn en misselijkheid.........................................................................................................................21
Wanneer zorgen maken over hoofdpijn?..............................................................................................................21
6.2 Secundaire hydrocefalie...........................................................................................................................21
6.3 Nystagmus................................................................................................................................................21
7 diagnose........................................................................................................................................21
8 behandeling...................................................................................................................................22
8.1 Chirurgie...................................................................................................................................................22
8.2 Radiotherapie...........................................................................................................................................22
8.3 Chemotherapie.........................................................................................................................................22
8.4 Behandeling van intracraniële druk pre-operatief...................................................................................22
Externe ventrikel drainage.........................................................................................................................22
8.5 Radiotherapie met protonen....................................................................................................................22
9 prognose........................................................................................................................................23
10 complicaties van behandeling......................................................................................................23
10.1 Hoge morbiditeit....................................................................................................................................23
3
The benefits of buying summaries with Stuvia:
Guaranteed quality through customer reviews
Stuvia customers have reviewed more than 700,000 summaries. This how you know that you are buying the best documents.
Quick and easy check-out
You can quickly pay through credit card or Stuvia-credit for the summaries. There is no membership needed.
Focus on what matters
Your fellow students write the study notes themselves, which is why the documents are always reliable and up-to-date. This ensures you quickly get to the core!
Frequently asked questions
What do I get when I buy this document?
You get a PDF, available immediately after your purchase. The purchased document is accessible anytime, anywhere and indefinitely through your profile.
Satisfaction guarantee: how does it work?
Our satisfaction guarantee ensures that you always find a study document that suits you well. You fill out a form, and our customer service team takes care of the rest.
Who am I buying these notes from?
Stuvia is a marketplace, so you are not buying this document from us, but from seller marthebraem. Stuvia facilitates payment to the seller.
Will I be stuck with a subscription?
No, you only buy these notes for $14.11. You're not tied to anything after your purchase.
Can Stuvia be trusted?
4.6 stars on Google & Trustpilot (+1000 reviews)
79202 documents were sold in the last 30 days
Founded in 2010, the go-to place to buy study notes for 14 years now